NCT01885702View on ClinicalTrials.gov

Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI

PHASE1/PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

October 31, 2010

Primary Completion Date

April 30, 2016

Study Completion Date

September 30, 2025

Conditions
Colorectal Cancer
Interventions
BIOLOGICAL

DC vaccination

DC vaccination

Trial Locations (1)

6500 HB

Radboud University Nijmegen Medical Centre, Nijmegen

All Listed Sponsors
lead

Radboud University Medical Center

OTHER

NCT01885702 - Dendritic Cell Vaccination in Patients With Lynch Syndrome or Colorectal Cancer With MSI | Biotech Hunter | Biotech Hunter